American National Bank & Trust (Virginia)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$763K Buy
9,903
+58
+0.6% +$4.61K 0.36% 75
2015
Q3
$811K Sell
9,845
-80
-0.8% -$7.12K 0.41% 71
2015
Q2
$875K Buy
9,925
+1,751
+21% +$161K 0.41% 71
2015
Q1
$722K Buy
8,174
+2,054
+34% +$182K 0.34% 80
2014
Q4
$508K Buy
6,120
+1,402
+30% +$116K 0.24% 98
2014
Q3
$398K Buy
4,718
+1,534
+48% +$124K 0.19% 113
2014
Q2
$258K Buy
+3,184
New +$250K 0.13% 119

Other funds holding NVS

American National Bank & Trust (Virginia)'s NVS Position: Q4 2015 in Review

American National Bank & Trust (Virginia) increased its Novartis (NVS) stake by 0.59% in Q4 2015, buying an estimated $4.61K and bringing the position to 9,903 shares worth $763K. The position accounts for 0.36% of the portfolio, ranked #75.

American National Bank & Trust (Virginia) first reported a position in NVS in Q2 2014 and has held it in 7 quarters since. The position peaked at $875K in Q2 2015. 927 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

  • American National Bank & Trust (Virginia) held 9,903 shares of Novartis worth $763K as of Q4 2015.
  • American National Bank & Trust (Virginia) bought 58 Novartis shares in Q4 2015, an estimated $4.61K.
  • Novartis made up 0.36% of American National Bank & Trust (Virginia)'s portfolio in Q4 2015, its #75 holding.
  • American National Bank & Trust (Virginia) first reported a position in Novartis in Q2 2014 and has held it in 7 quarters since.
  • American National Bank & Trust (Virginia)'s Novartis position peaked at $875K in Q2 2015.
  • 927 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on American National Bank & Trust (Virginia)'s 13F filing for Q4 2015, filed 9 Feb 2016.